DAWN
Day One Biopharmaceuticals Inc
NASDAQ: DAWN · HEALTHCARE · BIOTECHNOLOGY
$21.53
+0.00% today
Updated 2026-04-23
Market cap
$2.22B
P/E ratio
—
P/S ratio
14.06x
EPS (TTM)
$-1.04
Dividend yield
—
52W range
$6 – $22
Volume
4.5M
Day One Biopharmaceuticals Inc (DAWN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+14.9%
Last 4 quarters
Revenue YoY growth
+83.9%
Most recent quarter
EPS YoY growth
+66.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+9.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+25.0%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-24 | $-0.21 | -8.8% | $11.70 | $10.93 | -6.6% |
| 2025-11-04 | $-0.19 | +34.5% | $7.31 | $9.14 | +25.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.19 | $-0.21 | -8.8% | $53.72M | +83.9% |
| 2025-09-30 | $-0.29 | $-0.19 | +34.5% | $39.80M | -57.6% |
| 2025-06-30 | $-0.35 | $-0.29 | +17.4% | $33.91M | +313.9% |
| 2025-03-31 | $-0.42 | $-0.35 | +16.7% | $30.76M | — |
| 2024-12-31 | $-0.46 | $-0.63 | -36.2% | $29.21M | +5115.7% |
| 2024-09-30 | $-0.32 | $0.38 | +220.4% | $93.76M | — |
| 2024-06-30 | $-0.75 | $-0.05 | +93.3% | $8.19M | — |
| 2024-03-31 | $-0.66 | $-0.72 | -9.1% | — | — |
| 2023-12-31 | $-0.58 | $-0.64 | -10.3% | $560000.00 | — |
| 2023-09-30 | $-0.60 | $-0.54 | +10.0% | — | — |
| 2023-06-30 | $-0.61 | $-0.61 | +0.0% | — | — |
| 2023-03-31 | $-0.59 | $-0.59 | +0.0% | — | — |
Frequently asked questions
Has Day One Biopharmaceuticals Inc beaten earnings estimates?
Day One Biopharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +14.9% over the last 4 quarters.
How does DAWN stock react to earnings?
DAWN stock has moved an average of +9.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Day One Biopharmaceuticals Inc's revenue growth rate?
Day One Biopharmaceuticals Inc reported year-over-year revenue growth of +83.9% in its most recent quarter, with EPS growing +66.7% year-over-year.